Last10K.com

Respirerx Pharmaceuticals Inc. (RSPI) SEC Filing 8-K Material Event for the period ending Wednesday, February 27, 2019

Respirerx Pharmaceuticals Inc.

HISTORY TOOLS
CIK: 849636 Ticker: RSPI

View differences made from one to another to evaluate Respirerx Pharmaceuticals Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Respirerx Pharmaceuticals Inc..

Continue

Assess how Respirerx Pharmaceuticals Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Respirerx Pharmaceuticals Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Respirerx Pharmaceuticals Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.2: Additional Exhibits
Ticker: RSPI
CIK: 849636
Form Type: 8-K Corporate News
Accession Number: 0001493152-19-002869
Submitted to the SEC: Tue Mar 05 2019 4:05:32 PM EST
Accepted by the SEC: Tue Mar 05 2019
Period: Wednesday, February 27, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. New Agreement
  3. New Financial Obligation

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/rspi/0001493152-19-002869.htm